Biomedix Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Biomedix's estimated annual revenue is currently $55.8M per year.(i)
  • Biomedix's estimated revenue per employee is $297,000

Employee Data

  • Biomedix has 188 Employees.(i)
  • Biomedix grew their employee count by 35% last year.

Biomedix's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, ProductReveal Email/Phone
3
Customer Service ManagerReveal Email/Phone
4
Business developmt V.PReveal Email/Phone
5
Hospital Account Executive - SoutheastReveal Email/Phone
6
Senior Clinical SpecialistReveal Email/Phone
7
Strategic Account ExecutiveReveal Email/Phone
8
Strategic Account ExecutiveReveal Email/Phone
9
Clinical Support SpecialistReveal Email/Phone
10
Client Services AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M32-6%N/AN/A
#2
$279320M117607-45%N/AN/A
#3
$0.1M1-75%N/AN/A
#4
$10.6M497%N/AN/A
#5
$13.9M570%N/AN/A
#6
$56.4M19010%N/AN/A
#7
$9.9M465%N/AN/A
#8
$9.3M43-2%N/AN/A
#9
$12.9M5320%N/AN/A
#10
$6.7M31-11%N/AN/A
Add Company

What Is Biomedix?

Biomedix is a provider of front-line diagnostic solutions for delivering value-based care. We offer a mobile health assessment platform that centralizes data for analyzing population health across multiple chronic conditions, and supports a variety of diagnostic devices. Biomedix is the maker of PADnet, the market leader in front-line diagnostics for peripheral vascular disease. PADnet is the only diagnostic device that can support the identification of peripheral artery disease (PAD) and chronic venous insufficiency (CVI) through a unique collaborative care model, which enables the cost-effective delivery of care that optimizes patient outcomes.

keywords:N/A

N/A

Total Funding

188

Number of Employees

$55.8M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37.2M1886%N/A
#2
$56.4M19010%N/A
#3
$15M1934%N/A
#4
$15M193-6%N/A
#5
$59.1M199-5%N/A